Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
humans (6) 6
life sciences & biomedicine (6) 6
male (6) 6
science & technology (6) 6
middle aged (5) 5
aged (4) 4
neurosciences & neurology (4) 4
adult (3) 3
amyotrophic lateral sclerosis (3) 3
amyotrophic lateral sclerosis - genetics (3) 3
clinical neurology (3) 3
myasthenia gravis (3) 3
prognosis (3) 3
abridged index medicus (2) 2
activities of daily living (2) 2
amyotrophic lateral sclerosis - mortality (2) 2
biological and medical sciences (2) 2
disease progression (2) 2
medical sciences (2) 2
medicine & public health (2) 2
mutation (2) 2
myasthenia gravis - drug therapy (2) 2
neurology (2) 2
patients (2) 2
public health (2) 2
quality of life research (2) 2
receptors, cholinergic - immunology (2) 2
severity of illness index (2) 2
sociology, general (2) 2
superoxide dismutase - genetics (2) 2
adolescent (1) 1
adult; aged; antibodies, monoclonal, humanized; autoantibodies; double-blind method; drug resistance; female; humans; male; middle aged; myasthenia gravis; receptors, cholinergic; outcome assessment; severity of illness index; neurology (1) 1
age factors (1) 1
aged, 80 and over (1) 1
amyotrophic lateral sclerosis - cerebrospinal fluid (1) 1
amyotrophic lateral sclerosis - diagnosis (1) 1
amyotrophic lateral sclerosis - drug therapy (1) 1
amyotrophic lateral sclerosis - epidemiology (1) 1
amyotrophic lateral sclerosis - immunology (1) 1
amyotrophic lateral sclerosis - pathology (1) 1
amyotrophic lateral sclerosis - physiopathology (1) 1
analysis (1) 1
animals (1) 1
anti-bacterial agents - pharmacology (1) 1
anti-bacterial agents - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - pharmacology (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
autoantibodies - blood (1) 1
belgium - epidemiology (1) 1
biochemistry & molecular biology (1) 1
biomarkers - cerebrospinal fluid (1) 1
brief communication (1) 1
case-control studies (1) 1
cell survival - drug effects (1) 1
cell survival - physiology (1) 1
child (1) 1
complement (1) 1
correction (1) 1
cross-sectional studies (1) 1
cu/zn superoxide dismutase (1) 1
degenerative and inherited degenerative diseases of the nervous system. leukodystrophies. prion diseases (1) 1
delayed diagnosis - trends (1) 1
diagnosis, differential (1) 1
disease models, animal (1) 1
diseases of striated muscles. neuromuscular diseases (1) 1
dose-response relationship, drug (1) 1
double-blind method (1) 1
drug resistance (1) 1
eculizumab (1) 1
electrodiagnosis - standards (1) 1
electrodiagnosis - trends (1) 1
electromyography - standards (1) 1
electromyography - trends (1) 1
enzymes (1) 1
fatigue (1) 1
fatigue - drug therapy (1) 1
genes (1) 1
genetics & heredity (1) 1
genotype & phenotype (1) 1
health care sciences & services (1) 1
health policy & services (1) 1
hospitals (1) 1
immunoglobulins (1) 1
inflammation (1) 1
inflammation - drug therapy (1) 1
inflammation - immunology (1) 1
inflammation - mortality (1) 1
longitudinal studies (1) 1
medical colleges (1) 1
medicin och hälsovetenskap (1) 1
medicine and health sciences (1) 1
mice (1) 1
mice, transgenic (1) 1
microglia (1) 1
microglia - drug effects (1) 1
microglia - immunology (1) 1
microglia - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease
by Poesen, Koen and De Schaepdryver, Maxim and Stubendorff, Beatrice and Gille, Benjamin and Muckova, Petra and Wendler, Sindy and Prell, Tino and Ringer, Thomas M and Rhode, Heidrun and Stevens, Olivier and Claeys, Kristl G and Couwelier, Goedele and DʼHondt, Ann and Lamaire, Nikita and Tilkin, Petra and Van Reijen, Dimphna and Gourmaud, Sarah and Fedtke, Nadin and Heiling, Bianka and Rumpel, Matthias and Rödiger, Annekathrin and Gunkel, Anne and Witte, Otto W and Paquet, Claire and Vandenberghe, Rik and Grosskreutz, Julian and Van Damme, Philip
Neurology, ISSN 0028-3878, 06/2017, Volume 88, Issue 24, pp. 2302 - 2309
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Single-Blind Method | Diagnosis, Differential | Phosphorylation | Prognosis | Cross-Sectional Studies | Amyotrophic Lateral Sclerosis - genetics | Humans | Middle Aged | Male | Disease Progression | Neurofilament Proteins - cerebrospinal fluid | Young Adult | Amyotrophic Lateral Sclerosis - cerebrospinal fluid | Adolescent | Aged, 80 and over | Adult | Female | Aged | Biomarkers - cerebrospinal fluid | Child | Longitudinal Studies | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
by Howard, James F and Utsugisawa, Kimiaki and Benatar, Michael and Murai, Hiroyuki and Barohn, Richard J and Illa, Isabel and Jacob, Saiju and Vissing, John and Burns, Ted M and Kissel, John T and Muppidi, Srikanth and Nowak, Richard J and O'Brien, Fanny and Wang, Jing-Jing and Mantegazza, Renato and Mazia, Claudio Gabriel and Wilken, Miguel and Ortea, Carolina and Saba, Juliet and Rugiero, Marcelo and Bettini, Mariela and Vidal, Gonzalo and Garcia, Alejandra Dalila and Lamont, Phillipa and Leong, Wai-Kuen and Fyfe, Beverly and Roberts, Leslie and Jasinarachchi, Mahi and Wanschitz, Julia and Löscher, Wolfgang and De Bleecker, Jan and de Koning, Kathy and De Mey, Katrien and Mercelis, Rudy and Van Damme, Philip and Smetcoren, Charlotte and Stevens, Olivier and D'Hondt, Ann and Tilkin, Petra and Alves de Siqueira Carvalho, Alzira and Feder, David and Ambrosio, Daniel and Melo, Ana Paula and Rocha, Rosana and Rosa, Bruno and Augusto da Silva, Luiz and Gonçalves Geraldo, Jordana and da Penha Morita Ananias, Maria and Paiva, Gabriel and Pozo, Marina and Prando, Natalia and Dada Martineli Torres, Debora and Fernanda Butinhao, Cristiani and Coelho, Erica and Renata Cubas Volpe, Luciana and Duran, Gustavo and Gomes da Silva, Tamires Cristina and Otavio Maia Gonçalves, Luiz and Souza Duca, Luciana and Suriane Fialho, Tomás Augusto and Guerreiro, Alexandre and Mohr, Henrique and Pereira Martins, Maurer and da Cruz Pacheco, Daiane and de Cassia Santos, Aline and Bulle Oliveira, Acary Souza and Annes, Marcelo and Cavalcante Lino, Valeria and Miranda, Carolina and Souza, Iandra and Genge, Angela and Massie, Rami and Campbell, Natasha and Katzberg, Hans and Soltani, Mehran and Siddiqi, Zaeem and Phan, Celile and Blackmore, Derrick and Vohanka, Stanislav and Chmelikova, Magda and Cierny, Marek and Kurkova, Barbora and Zapletalova, Olga and Pitha, Jiri and Tyblova, Michaela and Wolfova, Marcela and Jurajdova, Ivana and Andersen, Henning and Harbo, Thomas and Vinge, Lotte and Mogensen, Anita and Højgaard, Joan and Witting, Nanna and Autzen, Anne Mette and Pedersen, Jane and Färkkilä, Markus and Atula, Sari and Erälinna, Juha-Pekka and Laaksonen, Mikko and Harrison, Tuula and ... and REGAIN Study Group and REGAIN Study Grp
Lancet neurology, ISSN 1474-4422, 12/2017, Volume 16, Issue 12, pp. 976 - 986
no | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Double-Blind Method | Myasthenia Gravis - blood | Outcome Assessment (Health Care) | Autoantibodies - blood | Humans | Middle Aged | Male | Antibodies, Monoclonal, Humanized - administration & dosage | Myasthenia Gravis - physiopathology | Antibodies, Monoclonal, Humanized - pharmacology | Adult | Female | Receptors, Cholinergic - immunology | Aged | Myasthenia Gravis - drug therapy | Drug Resistance | Studies | Neurology | Immunoglobulins | Activities of daily living | Myasthenia gravis | Transplants & implants | Neuromuscular junctions | Myasthenia | Patients | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Minocycline delays disease onset and mortality in a transgenic model of ALS
by Van Den Bosch, Ludo and Tilkin, Petra and Lemmens, Griet and Robberecht, Wim
Neuroreport, ISSN 0959-4965, 06/2002, Volume 13, Issue 8, pp. 1067 - 1070
Amyotrophic lateral sclerosis | Inflammation | Neurodegeneration | Microglia | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Miscellaneous | Medical sciences | Pharmacology. Drug treatments | Neuroprotective Agents - therapeutic use | Microglia - metabolism | Motor Activity - physiology | Spinal Cord - drug effects | Age Factors | Minocycline - pharmacology | Motor Activity - drug effects | Male | Amyotrophic Lateral Sclerosis - drug therapy | Motor Neurons - pathology | Dose-Response Relationship, Drug | Anti-Bacterial Agents - therapeutic use | Microglia - immunology | Neuroprotective Agents - pharmacology | Inflammation - drug therapy | Minocycline - therapeutic use | Spinal Cord - pathology | Female | Inflammation - mortality | Cell Survival - physiology | Motor Neurons - drug effects | Disease Models, Animal | Amyotrophic Lateral Sclerosis - immunology | Cell Survival - drug effects | Microglia - drug effects | Motor Neurons - immunology | Mice, Transgenic | Survival Rate | Treatment Outcome | Inflammation - immunology | Disease Progression | Amyotrophic Lateral Sclerosis - mortality | Spinal Cord - immunology | Animals | Anti-Bacterial Agents - pharmacology | Mice | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Eculizumab improves fatigue in refractory generalized myasthenia gravis
by Andersen, Henning and Mantegazza, Renato and Wang, Jing Jing and O’Brien, Fanny and Patra, Kaushik and Howard Jr, James F and REGAIN Study Grp and REGAIN Study Group and The REGAIN Study Group
Quality of life research, ISSN 0962-9343, 8/2019, Volume 28, Issue 8, pp. 2247 - 2254
Public Health | Terminal complement inhibition | Myasthenia gravis | Medicine & Public Health | Quality of Life Research | Eculizumab | Fatigue | Complement | Sociology, general | Neuro-QOL Fatigue | Quality of life | Health Care Sciences & Services | Public, Environmental & Occupational Health | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Activities of Daily Living | Placebos - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Fatigue - drug therapy | Humans | Middle Aged | Quality of Life | Female | Male | Receptors, Cholinergic - immunology | Outcome Assessment, Health Care | Myasthenia Gravis - drug therapy | Analysis | Activities of daily living | Index Medicus | Brief Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis
by Andersen, Henning and Mantegazza, Renato and Wang, Jing Jing and O’Brien, Fanny and Patra, Kaushik and Howard Jr, James F and REGAIN Study Group and The REGAIN Study Group
Quality of life research, ISSN 0962-9343, 8/2019, Volume 28, Issue 8, pp. 2255 - 2255
Quality of Life Research | Public Health | Medicine & Public Health | Sociology, general | Web portals | Medical colleges | Myasthenia gravis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis
by Reniers, Wendeline and Schrooten, Maarten and Claeys, Kristl G and Tilkin, Petra and D'Hondt, Ann and Van Reijen, Dimphna and Couwelier, Goedele and Lamaire, Nikita and Robberecht, Wim and Fieuws, Steffen and Van Damme, Philip
Amyotrophic lateral sclerosis and frontotemporal degeneration, ISSN 2167-8421, 07/2017, Volume 18, Issue 5-6, pp. 341 - 350
Prognosis, electromyography, electrodiagnostic testing, Awaji, revised El Escorial | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Prognosis | Survival Rate - trends | Amyotrophic Lateral Sclerosis - physiopathology | Humans | Middle Aged | Amyotrophic Lateral Sclerosis - diagnosis | Male | Amyotrophic Lateral Sclerosis - mortality | Electromyography - trends | Electrodiagnosis - standards | Time Factors | Electrodiagnosis - trends | Delayed Diagnosis - trends | Female | Aged | Electromyography - standards | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium
by Aguirre, T and Matthijs, G and Robberecht, W and Tilkin, P and Cassiman, J.-J
European journal of human genetics : EJHG, ISSN 1018-4813, 1999, Volume 7, Issue 5, pp. 599 - 602
Neuromuscular disease | Variants | Amyotrophic lateral sclerosis | Mutation analysis | Cu/Zn superoxide dismutase | SOD1 | Biochemistry & Molecular Biology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Superoxide Dismutase - genetics | Mutation | Belgium - epidemiology | Amyotrophic Lateral Sclerosis - genetics | Humans | Amyotrophic Lateral Sclerosis - epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The G93C Mutation in Superoxide Dismutase 1: Clinicopathologic Phenotype and Prognosis
by Régal, Luc and Vanopdenbosch, Ludo and Tilkin, Petra and Van Den Bosch, Ludo and Thijs, Vincent and Sciot, Rafael and Robberecht, Wim
Archives of neurology (Chicago), ISSN 0003-9942, 02/2006, Volume 63, Issue 2, pp. 262 - 267
Neurology | Biological and medical sciences | Medical sciences | Diseases of striated muscles. Neuromuscular diseases | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Superoxide Dismutase - genetics | Prognosis | Amyotrophic Lateral Sclerosis - genetics | Humans | Middle Aged | Male | Case-Control Studies | Amyotrophic Lateral Sclerosis - pathology | Phenotype | Pedigree | Adult | Female | Aged | Retrospective Studies | Genotype & phenotype | Enzymes | Spinal cord | Hospitals | Genes | Amyotrophic lateral sclerosis | Mutation | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study
by Van Damme, Philip and Tilkin, Petra and Mercer, Katarina Jansson and Terryn, Joke and D’Hondt, Ann and Herne, Nina and Tousseyn, Thomas and Claeys, Kristl G and Thal, Dietmar R and Zachrisson, Olof and Almqvist, Per and Nuttin, Bart and Jerling, Markus and Bernadotte, Folke and Haegerstrand, Anders and Robberecht, Wim
Brain Communications, Volume 2, Issue 2
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.